JF
LXRX icon

Jump Financial’s Lexicon Pharmaceuticals LXRX Stock Holding History

Jump Financial’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$62.8K Buy
+40,246
New +$58.5K ﹤0.01% 1780
2025
Q3 		– Sell
-15,993
Closed -$15.1K – 2028
2025
Q2 		$15.1K Buy
+15,993
New +$10.4K ﹤0.01% 1728
2023
Q3 		– Sell
-19,280
Closed -$44.2K – 2089
2023
Q2 		$44.2K Buy
19,280
+1,080
+6% +$2.87K ﹤0.01% 1729
2023
Q1 		$44.2K Buy
+18,200
New +$41.7K ﹤0.01% 1499
2022
Q1 		– Sell
-38,700
Closed -$152K – 1744
2021
Q4 		$152K Buy
+38,700
New +$188K 0.01% 1161

Other funds holding LXRX

AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
SC
Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Jump Financial's LXRX Position: Q1 2026 in Review

Jump Financial opened a new position in Lexicon Pharmaceuticals (LXRX) in Q1 2026: 40,246 shares worth $62.8K. The stake represents ﹤0.01% of the portfolio and ranks #1780 among its holdings. This is a return to the name: Jump Financial previously reported a position in LXRX as recently as Q2 2025.

Jump Financial first reported a position in LXRX in Q4 2021 and has held it in 5 quarters since. The position peaked at $152K in Q4 2021. 136 funds tracked by Wall St. Rank hold LXRX as of Q1 2026.

  • Jump Financial held 40,246 shares of Lexicon Pharmaceuticals worth $62.8K as of Q1 2026.
  • Lexicon Pharmaceuticals was a new Jump Financial position in Q1 2026.
  • Lexicon Pharmaceuticals made up ﹤0.01% of Jump Financial's portfolio in Q1 2026, its #1780 holding.
  • Jump Financial first reported a position in Lexicon Pharmaceuticals in Q4 2021 and has held it in 5 quarters since.
  • Jump Financial's Lexicon Pharmaceuticals position peaked at $152K in Q4 2021.
  • 136 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q1 2026.

Based on Jump Financial's 13F filing for Q1 2026, filed 14 May 2026.